In Depth 23 Nov 2023
The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy
…acts as an undercover agent to release other immune cells in the TME, as they would usually have much more barriers to entry. CT-0508: Carisma’s encouraging candidate in addressing HER2+…
